A. Merenda

Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network

V. Innao, A. Romano, V. Calafiore, 2019, Journal of clinical medicine.

Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine‐based high‐dose chemotherapy regimen

V. Pavone, F. Lanza, S. Santarone, 2015, British journal of haematology.

Every‐other‐day palonosetron plus aprepitant for prevention of emesis following induction chemotherapy for acute myeloid leukemia: A randomized, controlled study from the “Rete Ematologica Pugliese”

P. Mazza, V. Pavone, D. Mannina, 2019, Cancer medicine.